BERG, Genomics England Aim to Accelerate Development of New Diagnostics, Treatments

BERG has partnered with Genomics England in it’s ambitious 100,000 genomes project which aims to accelerate development of new diagnostics and treatments. The project focuses on patients with rare diseases and six common cancers.The BERG Interrogative Biology® Platform will allow the program to look beyond the genome and gain a more robust understanding of the cellular activity of diseases.